Frystyk J - Search Results

1

Enhanced anti-metastatic bioactivity of an IGF-TRAP re-engineered to improve physicochemical properties.

Vaniotis G, Moffett S, Sulea T, Wang N, Elahi SM, Lessard E, Baardsnes J, Perrino S, Durocher Y, Frystyk J, Massie B, Brodt P. Vaniotis G, et al. Among authors: frystyk j. Sci Rep. 2018 Nov 26;8(1):17361. doi: 10.1038/s41598-018-35407-2. Sci Rep. 2018. PMID: 30478273 Free PMC article.

2

Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups.

Holm JB, Baggesen E, Cronin-Fenton D, Frystyk J, Bruun JM, Christiansen P, Borgquist S. Holm JB, et al. Among authors: frystyk j. Sci Rep. 2024 Jun 24;14(1):14486. doi: 10.1038/s41598-024-64428-3. Sci Rep. 2024. PMID: 38914635 Free PMC article.

3

A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.

Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, De Meyts P, Larsen MB, Christiansen JS, Frystyk J. Chen JW, et al. Among authors: frystyk j. Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1149-55. doi: 10.1152/ajpendo.00410.2002. Epub 2003 Feb 25. Am J Physiol Endocrinol Metab. 2003. PMID: 12604504 Free article.

4

The growth hormone hypothesis - 2005 revision.

Frystyk J. Frystyk J. Horm Metab Res. 2005 Apr;37 Suppl 1:44-8. doi: 10.1055/s-2005-861362. Horm Metab Res. 2005. PMID: 15918110 Review.

5

Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum.

Jeyaratnaganthan N, Grønbaek H, Holland-Fischer P, Espelund U, Chen JW, Flyvbjerg A, Vilstrup H, Frystyk J. Jeyaratnaganthan N, et al. Among authors: frystyk j. Clin Endocrinol (Oxf). 2010 May;72(5):625-32. doi: 10.1111/j.1365-2265.2009.03707.x. Epub 2009 Sep 21. Clin Endocrinol (Oxf). 2010. PMID: 19769623

6

Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes.

Jeyaratnaganthan N, Højlund K, Kroustrup JP, Larsen JF, Bjerre M, Levin K, Beck-Nielsen H, Frago S, Hassan AB, Flyvbjerg A, Frystyk J. Jeyaratnaganthan N, et al. Among authors: frystyk j. Growth Horm IGF Res. 2010 Jun;20(3):185-91. doi: 10.1016/j.ghir.2009.12.005. Epub 2010 Jan 27. Growth Horm IGF Res. 2010. PMID: 20110184

7

Quantification of the GH/IGF-axis components: lessons from human studies.

Frystyk J. Frystyk J. Domest Anim Endocrinol. 2012 Aug;43(2):186-97. doi: 10.1016/j.domaniend.2011.11.005. Epub 2011 Nov 24. Domest Anim Endocrinol. 2012. PMID: 22153974 Review.

8

Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.

Frystyk J, Schou AJ, Heuck C, Vorum H, Lyngholm M, Flyvbjerg A, Wolthers OD. Frystyk J, et al. Eur J Endocrinol. 2012 Dec 10;168(1):1-8. doi: 10.1530/EJE-12-0518. Print 2013 Jan. Eur J Endocrinol. 2012. PMID: 23038624 Clinical Trial.

9

Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes.

Hjortebjerg R, Flyvbjerg A, Frystyk J. Hjortebjerg R, et al. Among authors: frystyk j. Expert Opin Ther Targets. 2014 Feb;18(2):209-24. doi: 10.1517/14728222.2014.858698. Epub 2013 Nov 21. Expert Opin Ther Targets. 2014. PMID: 24261835 Review.

10

Determination of IGFs and their binding proteins.

Hjortebjerg R, Frystyk J. Hjortebjerg R, et al. Among authors: frystyk j. Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):771-81. doi: 10.1016/j.beem.2013.08.010. Epub 2013 Sep 6. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 24275189 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters